📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65 (2018)

First Author: Georgiadis A

Attributed to: Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41434-018-0031-x

PubMed Identifier: 30046128

Publication URI: http://europepmc.org/abstract/MED/30046128

Type: Journal Article/Review

Parent Publication: Gene Therapy

Issue: 6

ISSN: 0969-7128